Cardi/o®
by Advanced TeleSensors
01 / 18
Investor Pitch · July 2026

An AI smoke detector
for the human heart.

Catching heart trouble early. Before it becomes a 2 a.m. emergency.

Presented bySajol Ghoshal · Tiffany Wey, MBA
Sensor
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Problem02 / 18
The Blind Spot

Late detection costs Medicare $35B on readmissions.

20%
Readmitted
Within 30 days of discharge
2/3
Preventable
Outside the clinic, between visits
$35B
Blind spot
2.3M patients × $15K readmit
Between visits. Between shifts. No one is watching the heart.
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Product03 / 18
Always Watching

The missing intelligence layer for the blind spot.

Continuous watch
Ambient sensing of heart & respiratory rate. No wearables. No compliance.
Predicts decline
ML flags abnormal cardiac events days before a crisis.
Clinicians act
Adjust medications inside existing workflows. No new tools.
$15,000 readmission → $300 doctor's visit.
≈ 50× return on every crisis prevented.
Sensor
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Real Use Case04 / 18
6-Day Early Warning

Not a sensor. An early-warning layer.

01
Always watching
24/7 contact-free HR, RR & HRV.
02
Predictive AI
Physiology-tuned ML flags decline up to 6 days early.
03
Early intervention
Clinicians act before a crisis. Fewer transfers.
Real patient · 30 days
HR (bpm) · RR (breaths/min)
EARLY WARNING6/16/66/116/166/216/267/1
Heart rate Respiratory rate
Early Warning → Early Intervention → Fewer Readmissions.
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Traction05 / 18
Live & Recurring

Cardi/o® is LIVE today, generating recurring revenue.

$215K
Revenue in 2025
+181% YoY
1,250+
Sensors deployed
Across 10+ nursing homes
3
RPM channel partners
Contracted and integrated
The model works. Early detection is the standard of care.
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Go-To-Market06 / 18
Channel Multiplier

Partner once. Thousands of beds.

Existing cardiologist relationships
Clinical trust from day one.
Integrated EMR workflows
Zero friction. No new software.
Massive reach
1,000 – 10,000 beds per partner.
Cardi/o®Early warningPartner 1EMR + RPMPartner 2EMR + RPMPartner 3EMR + RPMThousands of beds
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Business Model07 / 18
Subscription (SaaS)

Medicare pays for prevention.

$30
Per patient / month
$1,000 over 3 years
$9M
/ month at scale
At 300K patients
$108M
ARR at scale
90% gross margin
Enabled byMedicare CPT 99454 · reimbursed · predictable cash flow.
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Market Opportunity08 / 18
$1.5B Beachhead

Immediate ROI, and we've barely begun.

$1.5B
Beachhead
TAM $16B
SAM $4.5B
5M
High-risk cardiac patients unmonitored today
$16B TAM
RPM · 16% CAGR
$4.5B SAM
SNFs · nursing · home health
$1.5B Beachhead
1.3M high-risk patients
Sources: AMA & CMS
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Regulatory & Clinical09 / 18
Class II · 510(k) Pathway

A clear regulatory pathway.

2025 · TODAY
Monitoring live
Wellness monitor · 1,250+ deployed
JUN 2026
Registration complete
Class II medical device
DEC 2026
510(k) Clearance
Continuous cardiac monitoring
Clinical Validation
70 patients
Texas Cardiac Arrhythmia Institute · Austin, TX
Real-World Pilot
10 patients
PAM Health · rural Texas home-health
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Competition10 / 18
Our Advantage

Built for post-acute care.

Capability
Wearables
Cardi/o®
Heart rate
Respiratory rate
No patient compliance required
Early warning to clinicians
No clinical workflow disruption
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
IP Moat11 / 18
Barriers to Entry

Hard to copy.

01
Physiology-tuned algorithms
Proprietary ML trained on real-world cardiac & respiratory signals.
02
AI early-warning engine
Built for continuous clinical data — not consumer wearables.
03
Patents + trade secrets
6 granted patents. Exclusive NASA JPL license.
Anyone can buy a sensor. No one can buy our data, patents, or NASA license.
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Team12 / 18
Built for This Moment

Operators, cardiologists, deep-tech.

Core Leadership
Sajol Ghoshal
Co-founder & CEO
3 exits totaling $3B. Intel acquisition.
Tiffany Wey, MBA
VP Sales & Marketing
Medical device & senior living. Vayyar, Dele.
Jason Zagrodzky, M.D.
Chief Medical Officer
Cardiologist. Arrhythmia specialist.
Execution Backbone & Venture Partner
Frank Reeves
CFO/COO (fractional)
20+ yrs healthcare finance & RPM reimbursement.
Elisa Maldonado-Holmertz
FDA Regulatory & Quality
20 yrs FDA Class II registration.
Steve Monacos
Advisor · Founder & Scientist
NASA JPL · 40+ yrs non-contact sensing.
Alexander Dugom
Venture Partner · InoSwift
Commercial, clinical & regulatory. Corporate strategy to exit.
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Licensing Applications13 / 18
Beyond Healthcare · Near-Term

The same sensor. New verticals for licensing.

Search & Rescue drones
Airborne cardiac & respiratory sensing to detect survivors through debris, foliage, and darkness.
Altitude
40 – 100 ft
Environment
High interference
Disaster response · wilderness SAR · defense pilots
Armor & smart suits
Embed the Cardi/o sensor directly into body armor, tactical vests, and protective suits — vitals from the wearer without any skin contact.
Standoff
1 – 2 inches
Form factor
Panel-embedded
Defense · first responders · industrial safety
Same IP. New royalty streams through licensing partners.
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Exit Options14 / 18
Multiple Paths to Liquidity

At the intersection of AI · RPM · PAC.

AIRPMPACCardi/o®
MedTech & Device Leaders
Philips · Medtronic · GE · Abbott
Digital Health & RPM
ResMed · Teladoc · DexCom · Tapestry
Company
Price
Acquirer
BioTelemetry
$2.8B
Philips
Preventice
$925M
Boston Scientific
MatrixCare
$750M
ResMed
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Financials15 / 18
5-Year Projection

Recurring revenue compounds.

20252026202720282029$0.2M$1.2M$14M$47M$108M
Revenue EBITDA
2026 target: $1M ARR
~3,000 deployed sensors through RPM channel partners.
$108M in 4 years
Channels + direct to nursing homes @ 300K patients.
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
The Ask16 / 18
Bridge Round

Closing a $3M bridge — $1M open.

Already committed
$2M
Open
$1M
Use of Funds
  • → Scale RPM channel partnerships to drive $1M ARR
  • → FDA 510(k) submission for Class II clearance
  • → Key sales & clinical hires
Key Milestones
  • ✓ $1M ARR
  • ✓ FDA Class II compliance
Next
Series A: $8–15M
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Partnership17 / 18
Venture Studio Collaboration

Scaling with InoSwift.

InoSwift
Venture Studio

InoSwift is our operating partner across commercial, clinical, regulatory, and corporate strategy — and a venture partner on milestone-driven capital to carry Cardi/o® toward IPO or acquisition.

Commercial
Sales acceleration, RPM channel expansion & strategic partnerships.
Clinical
Research approvals, trial design, and evidence generation.
Regulatory
FDA Class II & 510(k) execution alongside our QA/RA team.
Corporate strategy
Milestone-driven runway toward IPO or strategic acquisition.
Venture Partner
Milestone-based capital
In discussion to fund toward exit.
Path To Liquidity
IPO or acquisition
Milestones structured with the studio.
Operating Leverage
Shared bench
GTM, RA/QA, corp-dev on tap.
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.
Cardi/o®
by Advanced TeleSensors
Closing18 / 18
Every day we wait

Who is watching your heart?

Every day we wait, 4,000 more patients face preventable readmissions. Put a smoke detector for the heart in every nursing home.

Invest in Cardi/o®sajol@advancedtelesensors.com
Sensor
Cardi/o® — Confidential · July 2026Advanced TeleSensors, Inc.